Form EFFECT NeuBase Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 2, 2024 |
| Accession Number: | 0001104659-24-075714 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Huawei Pioneers a New Computing Architecture for the AI Era: Making One Million Processors Work as One Computer - Summary of Roundtable Meeting Between Eric Xu and International Media Outlets on Septe
- TrustEngine Names Brandon Durham Vice President of Adoption and Partnerships
- Digital Twins in Defense: Lessons Learned, Emerging Opportunities and the Road Ahead
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
